Skip to main content

Gilead Prices COVID-19 Drug At $2,340 Per Patient In Developed Nations

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...

from NDTV News - Special https://ift.tt/3dKZIH5

Comments

Popular posts from this blog

Delhi Panel Asks Eateries To Display If Meat Served Is Halal Or Jhatka

All restaurants and shops selling or serving meat in east Delhi will have to mandatorily display boards specifying if it is halal or 'jhatka' meat, the highest decision-making body of the area's... from NDTV News - Special https://ift.tt/2NCVvsK